1,819
Views
15
CrossRef citations to date
0
Altmetric
Research Paper

Intention to get vaccinated against COVID-19 among the general population in France: Associated factors and gender disparities

ORCID Icon, , , , ORCID Icon &
Pages 3421-3432 | Received 18 Nov 2020, Accepted 16 Feb 2021, Published online: 22 Jul 2021

References

  • Larson HJ, De Figueiredo A, Xiahong Z, Schulz WS, Verger P, Johnston IG, Cook AR, Jones NS. The state of vaccine confidence 2016: global insights through a 67-country survey. EBioMedicine. 2016;12:295–301. doi:10.1016/j.ebiom.2016.08.042.
  • Gallup. Wellcome global monitor. First Wave Findings. https://wellcome.org/sites/default/files/wellcome-global-monitor-2018.pdf; 2019 [accessed 19 October 2020].
  • De Figueiredo A, Simas C, Karafillakis E, Paterson P, Larson HJ. Mapping global trends in vaccine confidence and investigating barriers to vaccine uptake: a large-scale retrospective temporal modelling study. The Lancet. 2020;396(10255):898–908. doi:10.1016/S0140-6736(20)31558-0.
  • Ward JK, Alleaume C, Peretti-Watel P; the COCONEL Group. The French public’s attitudes to a future COVID-19 vaccine: the politicization of a public health issue. Soc Sci Med. 2020;265:113414. doi:10.1016/j.socscimed.2020.113414.
  • Neumann-Böhme S, Varghese NE, Sabat I, Barros PP, Brouwer W, Van Exel J, Schreyögg J, Stargardt T. Once we have it, will we use it? A European survey on willingness to be vaccinated against COVID-19. Eur J HEalth Econ. 2020;21(7):977–82. doi:10.1007/s10198-020-01208-6.
  • Lazarus JV, Ratzan SC, Palayew A, Gostin LO, Larson HJ, Rabin K, Kimball S, El-Mohandes A, Global A. Survey of potential acceptance of a COVID-19 vaccine. Nat Med. 2020:1–4. doi:10.1038/s41591-020-1124-9.
  • Palamenghi L, Barello S, Boccia S, Graffigna G. Mistrust in biomedical research and vaccine hesitancy: the forefront challenge in the battle against COVID-19 in Italy. Eur J Epidemiol. 2020:1–4. doi:10.1007/s10654-020-00675-8.
  • Thunstrom L, Ashworth M, Finnoff D, S N. Hesitancy towards a COVID-19 vaccine and prospects for Herd immunity. SSRN Scholarly Paper. Rochester (NY): Social Science Research Network 2020. doi: 10.2139/ssrn.3593098.
  • Malik AA, S-am M, Elharake J, Omer SB. Determinants of COVID-19 vaccine acceptance in the US. EClinicalMedicine. 2020;26:100495. doi:10.1016/j.eclinm.2020.100495.
  • Padhi BK, Almohaithef MA Determinants of COVID-19 vaccine acceptance in Saudi Arabia: a web-based national survey. MedRxiv 2020, doi: 10.1101/2020.05.27.20114413.
  • Harapan H, Wagner AL, Yufika A, Winardi W, Anwar S, Gan AK, Setiawan AM, Rajamoorthy Y, Sofyan H, Mudatsir M. Acceptance of a COVID-19 vaccine in Southeast Asia: a cross-sectional study in Indonesia. Front Public Health. 2020:8. doi:10.3389/fpubh.2020.00381.
  • Nguyen T, Henningsen KH, Brehaut JC, Hoe E, Wilson K. Acceptance of a pandemic influenza vaccine: a systematic review of surveys of the general public. Infect Drug Resist. 2011;4:197–207. doi:10.2147/IDR.S23174.
  • Wu S, Su J, Yang P, Zhang H, Li H, Chu Y, Hua W, Li C, Tang Y, Wang Q. Factors associated with the uptake of seasonal influenza vaccination in older and younger adults: a large, population-based survey in Beijing, China. BMJ Open. 2017;7(9):e017459. doi:10.1136/bmjopen-2017-017459.
  • La EM, Trantham L, Kurosky SK, Odom D, Aris E, Hogea C. An analysis of factors associated with influenza, pneumoccocal, Tdap, and herpes zoster vaccine uptake in the US adult population and corresponding inter-state variability. Hum Vaccin Immunother. 2018;14(2):430–41. doi:10.1080/21645515.2017.1403697.
  • Applewhite A, Stancampiano FF, Harris DM, Manaois A, Dimuna J, Glenn J, Heckman MG, Brushaber DE, Sher T, Valery J-R, et al. Analysis of gender-based difference in adherence to influenza vaccination during the 2018-2019 season. J Prim Care Community Health. 2020;11:215013272095853. doi:10.1177/2150132720958532.
  • Raude J, A-l C-B, Setbon M. The 2009 pandemic H1N1 influenza vaccination in France: who accepted to receive the vaccine and why? PLoS Curr. 2010;2:RRN1188. doi:10.1371/currents.RRN1188.
  • Bish A, Yardley L, Nicoll A, Michie S. Factors associated with uptake of vaccination against pandemic influenza: a systematic review. Vaccine. 2011;29(38):6472–84. doi:10.1016/j.vaccine.2011.06.107.
  • Velan B, Kaplan G, Ziv A, Boyko V, L L-G. Major motives in non-acceptance of A/h1n1 flu vaccination: the weight of rational assessment. Vaccine. 2011;29(6):1173–79. doi:10.1016/j.vaccine.2010.12.006.
  • Peretti-Watel P, Raude J, Sagaon-Teyssier L, Constant A, Verger P, Beck F. Attitudes toward vaccination and the h1n1 vaccine: poor people’s unfounded fears or legitimate concerns of the elite? Soc Sci Med. 2014;109:10–18. doi:10.1016/j.socscimed.2014.02.035.
  • Jiménez-García R, Hernández-Barrera V, Lopez De Andres A, Jimenez-Trujillo I, Esteban-Hernández J, Carrasco-Garrido P. Gender influence in influenza vaccine uptake in Spain: time trends analysis (1995–2006). Vaccine. 2010;28(38):6169–75. doi:10.1016/j.vaccine.2010.07.029.
  • Pulcini C, Massin S, Launay O, Verger P. Factors associated with vaccination for Hepatitis B, Pertussis, Seasonal and Pandemic influenza among French general practitioners: a 2010 survey. Vaccine. 2013;31(37):3943–49. doi:10.1016/j.vaccine.2013.06.039.
  • Rey D, Fressard L, Cortaredona S, Bocquier A, Gautier A, Peretti-Watel P, Verger P; the Baromètre santé 2016 Group. Vaccine hesitancy in the French population in 2016, and its association with vaccine uptake and perceived vaccine risk–benefit balance. Eurosurveillance. 2018;23(17):17–00816. doi:10.2807/1560-7917.ES.2018.23.17.17-00816.
  • Endrich MM, Blank PR, Szucs TD. Influenza vaccination uptake and socioeconomic determinants in 11 European countries. Vaccine. 2009;27(30):4018–24. doi:10.1016/j.vaccine.2009.04.029.
  • Mamelund S-E, Bergsaker MAR. Vaccine history, gender and influenza vaccination in a household context. Vaccine. 2011;29(51):9441–50. doi:10.1016/j.vaccine.2011.10.035.
  • Peretti‐Watel P, Ward JK, Vergelys C, Bocquier A, Raude J, Verger P. Vaccine hesitancy, commitment and trust among parents of young children. Sociol Health Illn ‘I Think I Made The Right Decision … I Hope I’m Not Wrong’. 2019;41(6):1192–206. doi:10.1111/1467-9566.12902.
  • Peretti-Watel P, Larson HJ, Ward JK, Schulz WS, Verger P. Vaccine hesitancy: clarifying a theoretical framework for an ambiguous notion. PLoS Curr. 2015:7. doi:10.1371/currents.outbreaks.6844c80ff9f5b273f34c91f71b7fc289.
  • Insee. Consumption unit, https://www.insee.fr/en/metadonnees/definition/c1802; 2016 [accessed 8 November 2020].
  • Sautory O Redressement d’échantillons d’enquêtes auprès des ménages par calage sur marges. Document de travail de l’INSEE 1991, n° F 9103.
  • Yamey G, Schäferhoff M, Hatchett R, Pate M, Zhao F, McDade KK. Ensuring global access to COVID-19 vaccines. The Lancet. 2020;395(10234):1405–06. doi:10.1016/S0140-6736(20)30763-7.
  • Ward L, Draper JA. Review of the factors involved in older people’s decision making with regard to influenza vaccination: a literature review. J Clin Nurs. 2008;17(1):5–16. doi:10.1111/j.1365-2702.2006.01861.x.
  • Szucs TD, Müller D. Influenza vaccination coverage rates in five European countries—a population-based cross-sectional analysis of two consecutive influenza seasons. Vaccine. 2005;23(43):5055–63. doi:10.1016/j.vaccine.2005.06.005.
  • Kan T, Zhang J. Factors influencing seasonal influenza vaccination behaviour among elderly people: a systematic review. Public Health. 2018;156:67–78. doi:10.1016/j.puhe.2017.12.007.
  • Verger P, Bocquier A, Vergélys C, Ward JK, Peretti-Watel P. Flu vaccination among patients with diabetes: motives, perceptions, trust, and risk culture - a qualitative survey. BMC Public Health. 2018:569. doi:10.1186/s12889-018-5441-6.
  • Van Der Weerd W, Timmermans DR-M, Beaujean DJ-M-A, Oudhoff J, Van Steenbergen JE. Monitoring the level of government trust, risk perception and intention of the general public to adopt protective measures during the influenza A (H1N1) pandemic in the Netherlands. BMC Public Health. 2011;575. https://doi.10.1186/1471-2458-11-575.
  • Flanagan KL, Fink AL, Plebanski M, Klein SL. Sex and gender differences in the outcomes of vaccination over the life course. Annu Rev Cell Dev Biol. 2017;33(1):577–99. doi:10.1146/annurev-cellbio-100616-060718.
  • Eckel CC, Grossman PJ.Chapter 113 men, women and risk aversion: experimental evidence.Plott CR, Smith VL, editors. Handbook of experimental economics results. Vol. 1; 2008: p.1061–73. Elsevier. doi:10.1016/S1574-0722(07)00113-8
  • Borghans L, Heckman JJ, Golsteyn BHH, Meijers H. gender differences in risk aversion and ambiguity aversion. J Eur Econ Assoc. 2009;7(2–3):649–58. doi:10.1162/JEEA.2009.7.2-3.649.
  • Giubilini A, Savulescu J, Wilkinson D. COVID-19 vaccine: vaccinate the young to protect the old? J Law Biosci. 2020;7(1). doi:10.1093/jlb/lsaa050.
  • Watson J. Open letter to MR Mehra et al., and to R Horton (editor of The Lancet) Concerns regarding the statistical analysis and data integrity. The Lancet. 2020. doi:10.5281/zenodo.3862789.
  • To KK-W, Hung IF-N, Ip JD, Chu AW-H, Chan W-M, Tam AR, Fong CH-Y, Yuan S, Tsoi H-W, Chin-Ki Ng A, Lap-Yip Lee L, Wan P, Tso E, To W-K, Tsang D, Chan K-H, Huang J-D, Kok K-H, Chi-Chung Cheng V, Yuen K-Y.Coronavirus disease 2019 (COVID-19) re-infection by a phylogenetically distinct severe acute respiratory syndrome coronavirus 2 strain confirmed by whole genome sequencing. Clin Infect Dis. 2020. doi:10.1093/cid/ciaa1275
  • Statistica. Part des ménages ayant un accès internet en France de 2006 à 2018, https://fr.statista.com/statistiques/509227/menage-francais-acces-internet; 2019 [accessed 23 September 2020].
  • Armitage CJ, Conner M. Efficacy of the theory of planned behaviour: a meta-analytic review. Br J Social Psychol. 2001;40(4):471–99. doi:10.1348/014466601164939.
  • Ipsos. Global attitudes on a COVID-19 vaccine, http://www3.weforum.org/docs/WEF_survey_vaccine_confidence_2020.pdf; 2020 [accessed 23 September 2020].
  • World Economic Forum. Survey shown rising vaccine hesitancy threatening COVID-19 recovery, https://www.weforum.org/press/2020/11/survey-shows-rising-vaccine-hesitancy-threatening-covid-19-recovery/;2020 [accessed 10 November 2020].
  • The COCONEL Group. A future vaccination campaign against COVID-19 at risk of vaccine hesitancy and politicisation. Lancet Infect Dis. 2020;20(7):769–70. doi:10.1016/S1473-3099(20)30426-6.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.